| B19 | Changes in depression, anxiety and substance use during the COVID-19 pandemic in an HIV primary care population in the United States | E-poster | Depression and other psychiatric manifestations |
| D84 | Challenges with tracing women who do not revisit targeted health services for female sex workers in Zimbabwe, and recommendations for future practice | E-poster | Sex workers |
| D97 | Challenges of recommencing HIV pre-exposure prophylaxis (PrEP) use during the COVID-19 pandemic | E-poster | Pre-exposure prophylaxis |
| D60 | Challenges adolescents and young people living with HIV face in adhering to ART: the Nigerian experience | E-poster | Positive health, dignity, psychological well-being, and mental health |
| B20 | Cervical cancer screening yield and associated factors among women living with HIV in Uganda | E-poster | Malignancies (AIDS and non-AIDS related) |
| C28 | Castanea Sativa Mill. bark extract (ENC®) inhibits R5 and X4 HIV-1 strains infectivity in vitro | E-poster | Microbicides (including vaginal and rectal microbicides) |
| B60 | Caregivers perception on paedriatic lopinavir/ritonavir formulations for HIV-infected children at Baylor Clinic, Mwanza, Tanzania | E-poster | Drug formulations for infants and children |
| B76 | Cardiometabolic risk factor comparison between foreign and native born African American persons with HIV infection in a U.S. urban healthcare setting | E-poster | Clinical issues in other vulnerable populations |
| C41 | CAP016 PrEP in pregnancy - a phase 2b open-label randomised control safety study of daily oral TDF/FTC when used as pre-exposure prophylaxis for HIV prevention in pregnant and lactating women | E-poster | PrEP and pregnant women |
| B20 | Cancer among people living with HIV in Ontario, Canada: a population-based matched cohort study among individuals with and without HIV | E-poster | Malignancies (AIDS and non-AIDS related) |